Sequential intravesical chemoimmunotherapy with mitomycin C and bacillus Calmette-Guérin and with bacillus Calmette-Guérin alone in patients with carcinoma in situ of the urinary bladder: results of an EORTC genito-urinary group randomized phase 2 trial (30993)
AUTOR(ES)
Bohle, Andreas
FONTE
International braz j urol
DATA DE PUBLICAÇÃO
2011-04
RESUMO
Documentos Relacionados
- Long-term efficacy results of EORTC Genito-Urinary Group randomized phase 3 study 30911 comparing intravesical instillations of epirubicin, bacillus Calmette-Guérin, and bacillus Calmette-Guérin plus isoniazid in patients with intermediate- and high-risk stage Ta T1 urothelial carcinoma of the bladder
- Interstitial pneumonitis secondary to intravesical bacillus calmette-guerin for carcinoma in-situ of the bladder
- Bacillus Calmette-Guérin (BCG) Brazilian Backstage in Bladder Cancer
- Imaging appearance of granulomatous disease after intravesical Bacille Calmette-Guerin (BCG) treatment of bladder carcinoma
- THE PROPHYLACTIC VALUE OF BACILLUS CALMETTE-GUÉRIN